Drugs / High Dose Trivalent Inactivated Influenza Vaccine
High Dose Trivalent Inactivated Influenza Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01427309 | Sep 2011 → May 2013 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | High Dose Trivalent Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01427309 ↗ |
| Modality | Vaccine | “high-dose, trivalent, inactivated influenza vaccine (IIV3-HD)” PMID 25119609 ↗ Aug 2014 |
| Route | Intramuscular | “0.5 mL Intramuscular” NCT01427309 ↗ |